Luye Pharma Group Ltd (LUP) — Free Cash Flow Generation Index
Luye Pharma Group Ltd (LUP) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of €344.86 Million represents 1% of operating cash flow (€344.86 Million). Explore capital reinvestment ratio of Luye Pharma Group Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Luye Pharma Group Ltd Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Luye Pharma Group Ltd across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Luye Pharma Group Ltd.
Annual Free Cash Flow Generation for Luye Pharma Group Ltd (2016–2025)
Year-by-year Free Cash Flow Generation Index for Luye Pharma Group Ltd. Check Luye Pharma Group Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | €780.44 Million | €1.78 Billion | €1.00 Billion | ▲ +104.8% |
| 2024 | -9.18x | €-1.54 Billion | €167.76 Million | €1.71 Billion | ▼ -3505.8% |
| 2023 | 0.27x | €430.23 Million | €1.60 Billion | €1.17 Billion | ▼ -9.0% |
| 2022 | 0.30x | €490.14 Million | €1.65 Billion | €1.16 Billion | ▲ +104.0% |
| 2021 | -7.45x | €-1.36 Billion | €182.37 Million | €556.20 Million | ▼ -1483.4% |
| 2020 | -0.47x | €-486.43 Million | €1.03 Billion | €692.81 Million | ▲ +54.7% |
| 2019 | -1.04x | €-1.48 Billion | €1.42 Billion | €999.34 Million | ▲ +24.5% |
| 2018 | -1.38x | €-1.44 Billion | €1.05 Billion | €728.16 Million | ▼ -491.5% |
| 2017 | 0.35x | €338.92 Million | €964.10 Million | €507.32 Million | ▼ -77.2% |
| 2016 | 1.54x | €911.17 Million | €592.03 Million | €319.14 Million | — |